HIV and HCV testing at clinical encounters among people who inject drugs, 2013–2018—Opportunities for increased testing and prevention
- 19 September 2023
- journal article
- research article
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 30 (11) , 848-858
Abstract
People who inject drugs (PWID) with unsafe injection practices have substantial risk for HIV and hepatitis C virus (HCV) infections. We describe frequency of, and factors associated with, HIV and HCV testing during clinical encounters with PWID. Inpatient and Emergency Department clinical encounters at an Atlanta hospital were abstracted from medical records spanning January 2013–December 2018. We estimated frequency of HIV and HCV testing during injection drug use (IDU)‐related encounters among PWID without previous diagnoses. We assessed associations between patient factors and testing using generalized estimating equations models. HIV testing occurred in 39.3% and HCV testing occurred in 17.1% of eligible IDU‐related encounters. Testing was more likely in IDU‐related encounters during 2017–2018 than in encounters during 2013–2014; (HIV, AOR = 2.14, 95% CI, 1.32–3.49, p < .01). Testing was less likely among Black/African American patients compared to White patients (adjusted odds ratio [AOR]: HIV, AOR = 0.48, 95% confidence interval [CI], 0.33–0.72, p < .01); HCV, AOR = 0.41, 95% CI, 0.24–0.70, p < .01). This difference may be attributable to recent testing among Black patients in non‐IDU related encounters. HIV and HCV testing improved over time; however, missed opportunities for testing still existed. Strategies should aim to improve equitable HIV and HCV testing among PWID.Keywords
This publication has 41 references indexed in Scilit:
- Behavioral Characteristics and Injection Practices Associated with Skin and Soft Tissue Infections among People who Inject Drugs: A Community-Based Observational StudySubstance Abuse, 2017
- Missing the mark: ongoing missed opportunities for HIV diagnosis at an urban medical center despite universal screening recommendationsFamily Practice, 2016
- Low HIV testing among persons who inject drugs—National HIV Behavioral Surveillance, 20 U.S. cities, 2012Drug and Alcohol Dependence, 2016
- High-Yield Birth-Cohort Hepatitis C Virus Screening and Linkage to Care among Underserved African Americans, Atlanta, Georgia, 2012–2013Public Health Reports®, 2016
- A Comparison of Parallel and Integrated Models for Implementation of Routine HIV Screening in a Large, Urban Emergency DepartmentPublic Health Reports®, 2016
- A Cost Analysis of Hospitalizations for Infections Related to Injection Drug Use at a County Safety-Net Hospital in Miami, FloridaPLOS ONE, 2015
- Brief ReportJAIDS Journal of Acquired Immune Deficiency Syndromes, 2015
- Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysisInternational Journal of Epidemiology, 2013
- Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trialThe Lancet, 2013
- The effect of syringe exchange use on high-risk injection drug users: a cohort studyAIDS, 2000